accountFive years ago, few pharmaceutical executives would have believed that 2011 would bring a feverish scramble to invest in Russia. At the time, many b
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Russian Pharma: Localisation vs. Isolation - The Rise of Russia: Not Just a BRIC Anymore
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account